Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population
Ashley C. Bradford, W. David Bradford, Amanda J. Abraham, et al.
JAMA Internal Medicine (2018) Vol. 178, Iss. 5, pp. 667-667
Open Access | Times Cited: 235

Showing 1-25 of 235 citing articles:

Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations
Rosanna Smart, Rosalie Liccardo Pacula
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 644-663
Open Access | Times Cited: 243
Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose
Rahi Abouk, Rosalie Liccardo Pacula, David Powell
JAMA Internal Medicine (2019) Vol. 179, Iss. 6, pp. 805-805
Open Access | Times Cited: 207
Qualifying Conditions Of Medical Cannabis License Holders In The United States
Kevin F. Boehnke, Saurav Gangopadhyay, Daniel J. Clauw, et al.
Health Affairs (2019) Vol. 38, Iss. 2, pp. 295-302
Open Access | Times Cited: 181
Drivers of the fatal drug epidemic
Christopher J. Ruhm
Journal of Health Economics (2019) Vol. 64, pp. 25-42
Closed Access | Times Cited: 175
Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
Alex Capano, Richard D. Weaver, Elisa Burkman
Postgraduate Medicine (2019) Vol. 132, Iss. 1, pp. 56-61
Open Access | Times Cited: 145
The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion
Angélica Meinhofer, Allison Witman
Journal of Health Economics (2018) Vol. 60, pp. 177-197
Closed Access | Times Cited: 144
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Beth M. Wiese, Adrianne R. Wilson‐Poe
Cannabis and Cannabinoid Research (2018) Vol. 3, Iss. 1, pp. 179-189
Open Access | Times Cited: 136
Mapping cannabis potency in medical and recreational programs in the United States
Mary Catherine Cash, Katharine Cunnane, Chuyin Fan, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230167-e0230167
Open Access | Times Cited: 118
Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, et al.
Journal of Pain (2019) Vol. 20, Iss. 7, pp. 830-841
Open Access | Times Cited: 111
Can Labor Market Policies Reduce Deaths of Despair?
William H. Dow, Anna Godøy, Christopher Lowenstein, et al.
Journal of Health Economics (2020) Vol. 74, pp. 102372-102372
Open Access | Times Cited: 101
Marijuana use by middle-aged and older adults in the United States, 2015–2016
Benjamin H. Han, Joseph J. Palamar
Drug and Alcohol Dependence (2018) Vol. 191, pp. 374-381
Open Access | Times Cited: 100
THE EFFECTS OF RECREATIONAL MARIJUANA LEGALIZATION AND DISPENSING ON OPIOID MORTALITY
Nathan W. Chan, Jesse Burkhardt, Matthew Flyr
Economic Inquiry (2019) Vol. 58, Iss. 2, pp. 589-606
Closed Access | Times Cited: 81
Medical cannabis treatment for chronic pain: Outcomes and prediction of response
Joshua Aviram, Dorit Pud, Tamar Gershoni, et al.
European Journal of Pain (2020) Vol. 25, Iss. 2, pp. 359-374
Closed Access | Times Cited: 76
Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, et al.
Journal of Pain (2019) Vol. 20, Iss. 11, pp. 1362-1372
Open Access | Times Cited: 75
The Public Health Effects of Legalizing Marijuana
D. Mark Anderson, Daniel I. Rees
Journal of Economic Literature (2023) Vol. 61, Iss. 1, pp. 86-143
Open Access | Times Cited: 35
The clouded debate: A systematic review of comparative longitudinal studies examining the impact of recreational cannabis legalization on key public health outcomes
Maria Athanassiou, Alexandre Dumais, Inès Zouaoui, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 31
Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results from the Disease Burden Study 2019
Heng Shao, Heyue Du, Quan Gan, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 4, pp. 2485-2507
Open Access | Times Cited: 27
Marijuana legalization and opioid deaths
Neil K. Mathur, Christopher J. Ruhm
Journal of Health Economics (2023) Vol. 88, pp. 102728-102728
Closed Access | Times Cited: 22
Recreational marijuana legalization and prescription opioids received by Medicaid enrollees
Yuyan Shi, Di Liang, Yuhua Bao, et al.
Drug and Alcohol Dependence (2018) Vol. 194, pp. 13-19
Open Access | Times Cited: 72
Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis
Stephanie Lake, Zach Walsh, Thomas Kerr, et al.
PLoS Medicine (2019) Vol. 16, Iss. 11, pp. e1002967-e1002967
Open Access | Times Cited: 70
Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol
Samuel D. Banister, Jonathon C. Arnold, Mark Connor, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 5, pp. 2160-2175
Closed Access | Times Cited: 69
Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users
Thomas M. Clark, Jessica Jones, Alexis G. Hall, et al.
Cannabis and Cannabinoid Research (2018) Vol. 3, Iss. 1, pp. 259-271
Open Access | Times Cited: 68
Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study
Philippe Lucas, Susan Boyd, M‐J Milloy, et al.
Pain Medicine (2020) Vol. 22, Iss. 3, pp. 727-739
Open Access | Times Cited: 66
High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis
M. Eugenia Socías, Evan Wood, Stephanie Lake, et al.
Addiction (2018) Vol. 113, Iss. 12, pp. 2250-2258
Open Access | Times Cited: 64
Can policy affect initiation of addictive substance use? Evidence from opioid prescribing
Daniel W. Sacks, Alex Hollingsworth, Thủy Nguyễn, et al.
Journal of Health Economics (2020) Vol. 76, pp. 102397-102397
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top